Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation - 26/08/11
Doi : 10.1016/j.amjcard.2004.05.037
Emmanuel M. Kanoupakis, MD, Emmanuel G. Manios, MD, Hercules E. Mavrakis, MD, Panos G. Tzerakis, MD, Helen K. Mouloudi, MD, Panos E. Vardas, MD, PhD ⁎ 
Department of Cardiology, Heraklion University Hospital, Heraklion, Greece
*Dr. Vardas's address is: Cardiology Department, Heraklion University Hospital, PO Box 1352 Stavrakia, Heraklion, Crete, Greece
Riassunto |
Pretreatment with antiarrhythmic agents could improve cardioversion and recurrence rates in patients with persistent atrial fibrillation. In a prospective controlled trial, 145 patients were randomly assigned to treatment with carvedilol, amiodarone, or placebo for 4 weeks before electrical cardioversion. Although the 2 drugs had similar effects on cardioversion rates, amiodarone was superior in terms of sinus rhythm maintenance after conversion.
Il testo completo di questo articolo è disponibile in PDF.© 2004
Excerpta Medica Inc. Tutti i diritti riservati.
Vol 94 - N° 5
P. 659-662 - settembre 2004 Ritorno al numero
Articolo precedente
- Prevalence and determinants of breast arterial calcium in women at high risk of cardiovascular disease
- Angela H.E.M. Maas, Yvonne T. van der Schouw, Willem P. Th.M. Mali, Yolanda van der Graaf
- Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting
- Peter R. Kowey, Daniel Yannicelli, Ezra Amsterdam, COPPA-II Investigators * †
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?